Eli Lilly & Recalls
5 recalls on record · November 21, 2018 to April 24, 2024 · Drugs
Recalls by year
18
21
24
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 24, 2024DrugsFDA
Eli Lilly & Company recalls Sterile Diluent, HUMALOG U-100 (insulin lispro injection), HUMULIN R U-100 REGULAR (insulin human injection), Insulin Li
Hazard: CGMP Deviations
October 20, 2021DrugsFDA
Eli Lilly & Company recalls Glucagon Emergency Kit for Low Blood Sugar, Glucagon for Injection, 1 mg per vial; Diluent for Glucagon, 1 mL syringe. R
Hazard: SUBPOTENT DRUG: Vial contained a liquid substance, instead of the expected powder substance. There was also a lack of full drug effect upon administration.
September 1, 2021DrugsFDA
Eli Lilly & Company recalls Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46
Hazard: Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.
August 18, 2021DrugsFDA
Eli Lilly & Company recalls Zyprexa Intramuscular, Olanzapine for Injection, 10 MG per Single Use Vial, Rx only, Marketed by: Lilly USA, LLC, Indian
Hazard: cGMP deviations: Atypical appearance, decrease in size and change in color of the lyophilized cake of drug product.
November 21, 2018DrugsFDA
Eli Lilly & Co recalls ERBITUX CETUXIMAB Injection, 200 mg/100 mL (2 mg/mL), 100 mL per single-use vial, Rx only, Manufactured by: ImClone LLC
Hazard: Labeling: Missing label; potential for missing primary container label on the vial.